• Any Stage I ovarian stromal tumor will be treated with surgery to remove the affected ovary. Most patients will be watched after the surgical procedure and will not require additional treatment. When a Stage I tumor does come back following surgery, it is known as a high risk tumor. High risk tumors can be extremely large, poorly differentiated, or may have ruptured during the surgery. Patients who are diagnosed with high risk Stage I ovarian stromal tumors are generally given three options following surgery. These patients can be watched closely, given chemotherapy, or, in very rare cases, treated with radiation therapy.
• Stage II, III and IV ovarian stromal tumors are surgically treated to stage and debulk the cancer, followed by chemotherapy or hormone treatments. When chemotherapy is used, it is generally the same type used in the treatment of germ cell tumors (bleomycin, etoposide and cisplatin). In some cases, carboplatin and paclitaxel can be used together. Women who are unable to tolerate chemotherapy may be given hormone treatments to address their Stage II, III and IV ovarian stromal tumor. Hormone treatments can include Lupron, Zoladex, an aromatase inhibitor or tamoxifen. In very rare cases, radiation could be used to treat a Stage II, III and IV ovarian stromal tumor following surgery, when chemotherapy is not an option.
• Ovarian stromal tumors which come back after undergoing treatment are considered recurrent. The outlook could still be fairly good in this case because these tumors will most often grow slowly. At some point chemotherapy may be used, or surgery may be repeated. Some women with ovarian stromal tumors which recur could choose to take part in a clinical trial.  Stromal tumors which produce hormones will need to have the hormone blood levels checked regularly. In some instances, the level of inhibin will increase, telling doctors the tumor has recurred.

Did you use Baby Powder with Talc for feminine hygiene? Were You a Victim of Talcum Powder Ovarian Cancer?

If you have been following the Johnson & Johnson talcum powder ovarian cancer lawsuits, you are aware that jurors have found in favor of the plaintiffs in the first three trials. The first trial was decided in 2013, in favor of plaintiff Deane Berg who developed ovarian cancer after using J & J talcum powder for feminine hygiene for more than thirty years. The jury found Johnson & Johnson negligent, although Berg received no damages, a decision upheld by a South Dakota federal judge. In February 2016, a Missouri jury awarded the family of Jacqueline Fox $72 million in damages. Fox developed ovarian cancer after using J & J talcum powder for feminine hygiene, for more than three decades. Fox died a few months prior to the trial, making the talcum powder ovarian cancer lawsuit a wrongful death case. The jury allocated $10 million for compensatory damages, and $62 million for punitive damages.

A third talcum powder lawsuit was decided in May 2016, again, in favor of plaintiff Gloria Ristesund. Ristesund developed ovarian cancer after using J & J baby powder with talc and Shower to Shower with talc for feminine hygiene for more than thirty-five years. Ristesund was awarded $55 million--$5 million in compensatory damages and $50 million in punitive damages. Johnson & Johnson continues to maintain there is no scientific basis for claims of baby powder cancers, therefore the company had no responsibility to warn women of the potential dangers. Many women have questions regarding the link between ovarian cancer and talcum powder as well as questions regarding ovarian cancer and the various treatments for the disease.

Did You Use Talcum Powder for Feminine Hygiene?

If you are a victim of ovarian cancer and you used baby powder with talc for feminine hygiene, it could be beneficial to speak with an experienced talcum powder ovarian cancer attorney. Obtaining talcum powder ovarian cancer legal help as quickly as possible can make this difficult time at least a bit easier. You may be entitled to compensation for your injuries.